These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22262077)

  • 1. Fatty heart, cardiac damage, and inflammation.
    Guzzardi MA; Iozzo P
    Rev Diabet Stud; 2011; 8(3):403-17. PubMed ID: 22262077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial, perivascular, and epicardial fat.
    Iozzo P
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S371-9. PubMed ID: 21525485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
    Kerr M; Dodd MS; Heather LC
    Clin Sci (Lond); 2017 Aug; 131(16):2079-2094. PubMed ID: 28739841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low cardiac lipolysis reduces mitochondrial fission and prevents lipotoxic heart dysfunction in Perilipin 5 mutant mice.
    Kolleritsch S; Kien B; Schoiswohl G; Diwoky C; Schreiber R; Heier C; Maresch LK; Schweiger M; Eichmann TO; Stryeck S; Krenn P; Tomin T; Schittmayer M; Kolb D; Rülicke T; Hoefler G; Wolinski H; Madl T; Birner-Gruenberger R; Haemmerle G
    Cardiovasc Res; 2020 Feb; 116(2):339-352. PubMed ID: 31166588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary eicosapentaenoic acid supplementation accentuates hepatic triglyceride accumulation in mice with impaired fatty acid oxidation capacity.
    Du ZY; Ma T; Liaset B; Keenan AH; Araujo P; Lock EJ; Demizieux L; Degrace P; Frøyland L; Kristiansen K; Madsen L
    Biochim Biophys Acta; 2013 Feb; 1831(2):291-9. PubMed ID: 23085008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathophysiological role of oxidized cholesterols in epicardial fat accumulation and cardiac dysfunction: a study in swine fed a high caloric diet with an inhibitor of intestinal cholesterol absorption, ezetimibe.
    Shimabukuro M; Okawa C; Yamada H; Yanagi S; Uematsu E; Sugasawa N; Kurobe H; Hirata Y; Kim-Kaneyama JR; Lei XF; Takao S; Tanaka Y; Fukuda D; Yagi S; Soeki T; Kitagawa T; Masuzaki H; Sato M; Sata M
    J Nutr Biochem; 2016 Sep; 35():66-73. PubMed ID: 27416363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial metabolism and cardiac performance in obesity and insulin resistance.
    Banerjee S; Peterson LR
    Curr Cardiol Rep; 2007 Apr; 9(2):143-9. PubMed ID: 17430682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance.
    Abdesselam I; Pepino P; Troalen T; Macia M; Ancel P; Masi B; Fourny N; Gaborit B; Giannesini B; Kober F; Dutour A; Bernard M
    J Cardiovasc Magn Reson; 2015 Nov; 17():95. PubMed ID: 26546347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunction.
    Kienesberger PC; Pulinilkunnil T; Sung MM; Nagendran J; Haemmerle G; Kershaw EE; Young ME; Light PE; Oudit GY; Zechner R; Dyck JR
    Mol Cell Biol; 2012 Feb; 32(4):740-50. PubMed ID: 22158969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy.
    Shoghi KI; Finck BN; Schechtman KB; Sharp T; Herrero P; Gropler RJ; Welch MJ
    Circ Cardiovasc Imaging; 2009 Sep; 2(5):373-81. PubMed ID: 19808625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH.
    Serpillon S; Floyd BC; Gupte RS; George S; Kozicky M; Neito V; Recchia F; Stanley W; Wolin MS; Gupte SA
    Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H153-62. PubMed ID: 19429815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload.
    Chess DJ; Khairallah RJ; O'Shea KM; Xu W; Stanley WC
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1585-93. PubMed ID: 19767529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High fat diet induced diabetic cardiomyopathy.
    Dirkx E; Schwenk RW; Glatz JF; Luiken JJ; van Eys GJ
    Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):219-25. PubMed ID: 21571515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge.
    Gutiérrez-Cuevas J; Sandoval-Rodriguez A; Meza-Rios A; Monroy-Ramírez HC; Galicia-Moreno M; García-Bañuelos J; Santos A; Armendariz-Borunda J
    Cells; 2021 Mar; 10(3):. PubMed ID: 33809061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipotoxicity in the heart.
    Borradaile NM; Schaffer JE
    Curr Hypertens Rep; 2005 Dec; 7(6):412-7. PubMed ID: 16386196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Glucose Oxidation, Reduced Insulin Secretion, and a Fatty Heart May Be Protective Adaptions in Ischemic CAD.
    Hannukainen JC; Lautamäki R; Mari A; Pärkkä JP; Bucci M; Guzzardi MA; Kajander S; Tuokkola T; Knuuti J; Iozzo P
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2701-10. PubMed ID: 27045985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose uptake and lipid metabolism are impaired in epicardial adipose tissue from heart failure patients with or without diabetes.
    Burgeiro A; Fuhrmann A; Cherian S; Espinoza D; Jarak I; Carvalho RA; Loureiro M; Patrício M; Antunes M; Carvalho E
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E550-64. PubMed ID: 26814014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust suppression of cardiac energy catabolism with marked accumulation of energy substrates during lipopolysaccharide-induced cardiac dysfunction in mice.
    Umbarawan Y; Syamsunarno MRAA; Obinata H; Yamaguchi A; Sunaga H; Matsui H; Hishiki T; Matsuura T; Koitabashi N; Obokata M; Hanaoka H; Haque A; Kunimoto F; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
    Metabolism; 2017 Dec; 77():47-57. PubMed ID: 28941596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced oxidative stress sensitizes the mitochondrial permeability transition pore to opening in heart from Zucker Fa/fa rats with type 2 diabetes.
    Riojas-Hernández A; Bernal-Ramírez J; Rodríguez-Mier D; Morales-Marroquín FE; Domínguez-Barragán EM; Borja-Villa C; Rivera-Álvarez I; García-Rivas G; Altamirano J; García N
    Life Sci; 2015 Nov; 141():32-43. PubMed ID: 26407476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.